Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK)

Molecular Pharmacology

Volumn 60, Issue 5, 2001, Pages 1100-1111

  Baillie, George ^a   Mackenzie, Simon J ^a   Houslay, Miles D ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP PHOSPHODIESTERASE; INDOMETACIN; MEPACRINE; MITOGEN ACTIVATED PROTEIN KINASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE IV; PROSTAGLANDIN E2;

AMINO TERMINAL SEQUENCE; AORTA MEDIA; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; COMPLEX FORMATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034766764     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.5.1100     Document Type: Article

References (48)

1. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells
2. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase. PDE-4D3
3. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases
4. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase (PDE4) family form a discrete module via electrostatic interactions
5. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
6. Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: A diverse family of regulatory enzymes
7. A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs
8. Characterisation of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene
9. Protein determination in biological samples
10. AKAPs: From structure to function
11. The molecular biology of cyclic nucleotide phosphodiesterases
12. Determination of the cAMP-dependent protein kinase activity ratio in intact tissues
13. New insights into the control of MAP kinase pathways
14. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells
15. Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membrane
16. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase, HSPDE4D3 by phosphorylating it at Ser579
17. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model
18. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling
19. Tailoring cAMP signalling responses through isoform multiplicity
20. The multi-enzyme PDE4 cyclic AMP specific phosphodiesterase family: Intracellular targeting, regulation and selective inhibition by compounds exerting anti-inflammatory and anti-depressant actions
21. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells
22. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase
23. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart
24. Cleavage of structural proteins during assembly of the head of bacteriophage T4
25. Signal transduction through MAP kinase cascades
26. Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain
27. cPLA2 is phosphorylated and activated by MAP kinase
28. Phosphorylation-mediated activation and translocation of the cyclic AMP- specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting
29. ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases: The involvement of C-terminal docking sites and N-terminal UCR regions
30. The action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of CREB and p38 MAP kinase in U937 monocytic cells
31. Stimulation of p70S6 kinase via a growth hormone controlled PI-3 kinase pathway leads to the activation of a PDE4 cAMP specific phosphodiesterases in 3T3-F442A preadipocytes
32. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families
33. An intrinsic and a peripheral protein constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes
34. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms
35. Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle
36. Molecular cloning and characterization of the novel cAMP specific phosphodiesterase, PDE4A10
37. Asthma therapy for the 21st century
38. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP
39. Inhibition by SKF 525A and quinacrine of endogenous glibenclamide- sensitive K+ channels in follicle-enclosed Xenopus oocytes
40. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
41. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation
42. Proposal for pharmacologically distinct conformers of PDE4
43. 2 receptor function
44. Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity
45. Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function
46. Multiple cyclic nucleotide phosphodiesterase activities from rat brain
47. Phosphodiesterase isozymes: Molecular targets for novel anti-asthma agents
48. The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform